This inventor holds 5 USPTO granted patents and 13 published patent applications and 3 EPO patents. Top assignee: Alexion Pharmaceuticals, Inc.. Active years: 2022-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022-2025
Title: The Innovations of Xiang Gao
Introduction
Xiang Gao is a prominent inventor based in Guilford, CT (US), known for his significant contributions to the field of medicine. With a total of 5 patents, he has made remarkable strides in developing treatments for serious health conditions affecting pediatric patients.
Latest Patents
Among his latest patents are two notable innovations. The first patent focuses on the dosage and administration of anti-C5 antibodies for the treatment of atypical hemolytic uremic syndrome (aHUS) in pediatric patients. This patent provides methods for clinical treatment using an anti-C5 antibody or an antigen binding fragment thereof. The second patent addresses the treatment of paroxysmal nocturnal hemoglobinuria (PNH) in pediatric patients, also utilizing an anti-C5 antibody or its antigen binding fragment.
Career Highlights
Xiang Gao is currently associated with Alexion Pharmaceuticals, Inc., where he continues to work on groundbreaking medical innovations. His expertise in the field has led to advancements that significantly improve patient care and treatment outcomes.
Collaborations
Xiang collaborates with talented professionals, including Rajendra Pradhan and Lori Payton, who contribute to the innovative environment at Alexion Pharmaceuticals.
Conclusion
Xiang Gao's work exemplifies the impact of innovation in medicine, particularly in developing treatments for pediatric patients. His patents reflect a commitment to improving health outcomes and advancing medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile